OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy combo tested for head and neck cancer patients
Disease control CompletedThis study tested whether giving the immunotherapy drug durvalumab along with radiation works better than the standard cetuximab plus radiation for people with advanced head and neck cancer who cannot take the usual chemotherapy drug cisplatin. The trial enrolled 196 participants…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
Real-world data sheds light on HPV throat cancer treatments
Knowledge-focused CompletedThis study looked at 662 patients with HPV-positive throat cancer that had spread or come back. Researchers collected information on who these patients are, what treatments they received (pembrolizumab or nivolumab, with or without chemotherapy), and how well those treatments wor…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC